Cases 1 - 10 of 87
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Aurobindo Pharma Ltd.
as 5:2020cv00023
Plaintiff:
Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and others
Defendant:
Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2018cv00226
Plaintiff:
Allergan USA, Inc., Allergan Sales, LLC, Forest Laboratories Holdings, LTD. and others
Defendant:
Sandoz Inc., Aurobindo Pharma, LTD., Mylan Pharmaceuticals Inc. and others
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. HETERO LABS LIMITED et al
as 2:2017cv03387
Plaintiff:
CELGENE CORPORATION
Defendant:
HETERO LABS LIMITED, HETERO LABS LIMITED UNIT-V, HETERO DRUGS LIMITED and others
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al
as 1:2017cv00483
Plaintiff:
Bayer Intellectual Property GMBH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Bristol-Myers Squibb Company et al v. Aurobindo Pharma USA Inc.
as 1:2017cv00374
Defendant:
Aurobindo Pharma USA Inc., Indoco Remedies Ltd., Dr. Reddy's Laboratories Inc. and others
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Cause Of Action: 35 U.S.C. § 271
Shionogi Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2017cv00072
Plaintiff:
Shionogi Inc. and Andrx Labs, L.L.C.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 145
NOVARTIS AG et al v. AUROBINDO PHARMA LTD. et al
as 2:2017cv00389
Plaintiff:
NOVARTIS AG , NOVARTIS PHARMACEUTICALS CORPORATION , MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant:
AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 15 U.S.C. § 1126
AbbVie Inc. et al v. Aurobindo Pharma Limited et al
as 1:2017cv00047
Plaintiff:
AbbVie Inc. and Abbvie Deutschland GMBH & Co. KG
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis AG et al v. Aurobindo Pharma Ltd. et al
as 1:2017cv00048
Plaintiff:
Novartis AG , Novartis Pharmaceuticals Corporation , Mitsubishi Tanabe Pharma Corporation and others
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 145
Sanofi-Aventis U.S. LLC et al v. Aurobindo Pharma USA, Inc., et al.
as 1:2016cv01299
Plaintiff:
Sanofi-Aventis U.S. LLC , Aventisub LLC , Sanofi and others
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
